SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!
MENUMENU
  • DR. LEGATO
    • Scientific Bio
    • Curriculum Vitae
    • Gender Medicine Editorials
    • Selected Articles
  • ABOUT US
    • Just The Facts
    • Our Logo
    • Our Team
    • Our Goals
    • Our Mission
  • ABOUT GSM
    • Suggested Reading
    • Men’s Health
    • Women’s Health
  • PUBLICATIONS
    • Journal
    • Scientific Publications
  • LOGIN

The Foundation For Gender-Specific Medicine

MENUMENU
  • Home
  • Grants
  • Blog
  • News
  • Events
  • Books
  • Gala
  • Find A Doctor
  • Board Of Directors
  • Contact Us
DONATE
  • Home
  • blog
  • Dr. Legato's Blog
  • New Leukemia and Lymphoma Treatment Shows Promise
February 28, 2021

New Leukemia and Lymphoma Treatment Shows Promise

New Leukemia and Lymphoma Treatment Shows Promise

by Rose-Marie Brandwein / Monday, 24 July 2017 / Published in Dr. Legato's Blog

Young adults and children suffering with leukemia and lymphoma now have hope as a new CAR-T Therapy Tisagenlecleucel, developed and manufactured by Novartis, has been recommended by an oncology advisory panel of The US Food and Drug Administration (FDA). Many experts believe CAR-T Therapy presents a paradigm shift in how we approach and treat cancer. However, CAR-T Therapy is not without controversy due to its serious and sometimes deadly side effects such as fevers, chills, seizures, hallucinations, organ failure and in some rare cases fatal brain swelling. However, for those with little hope, it is still a lifeline.

Until now, Chimeric Antigen Receptor (CAR) technologies haven’t been as successful. CAR-T Therapy entails genetically engineering a patient’s own immune cells or T-cells which are unable to function properly to combat cancer or unable to recognize cancer cells. The process involves collecting the patient’s T-cells, engineering them by attaching antigen receptors to the T-cells and then reinfusing them into the patient. These altered T-cells are strengthened and better able to target and destroy cancer cells throughout the body.

In a previous trial, Novartis reported 83% of patients went into remission after the treatment and many remain in remission. However, long-term results are still unknown.

Novartis is also testing the treatment’s effectiveness on non-Hodgkin’s Lymphoma, Multiple Myeloma and solid tumors.

Novartis’ new treatment may be approved by the end of the year heralding a new phase in cancer treatment.

Facebook Comments
Avatar
Rose-Marie Brandwein

Strategic Communications Professional/Content Strategist/Marketing Communications Consultant

1
SHARES
ShareTweet
Tagged under: Cancer

What you can read next

The Word According to AARP—Find a Female Doctor!1
The Word According to AARP—Find a Female Doctor!
Christmas tree with decoration
Wishing all of you the happiest of holiday seasons!
closeup of two pieces of a puzzle forming a heart
A Token of My Affection

Subscribe to receive Dr. Legato's weekly newsletter.

From Dr. Legato’s Blog

  • Pregnancy During the Pandemic: What’s lost when women are left out
  • COVID-19 Update: When is a vaccine coming?  How effective will it be?
  • Varicose Veins
  • Split Ends Split Ends
  • Are Hair Dyes Safe?
  • Fainting
  • I wear an underwire bra, am I increasing my risk of cancer? breast pimple illustration
  • When Your Plastic Heart Changes It’s Structure and Function to Produce What You Need Doctors stethoscope
  • Does Drinking Wine Prevent Heart Attacks? People hands with wine glasses
  • Ravages Of The Covid Pandemic
  • ​Memorial For Harold Burson With Great Sadness
  • Online Video Medical Consultation Clinic waiting room
  • Vaginal Deodorants Vaginal Deodorants bottle
  • Exercise Exercise for an active life
  • Douching douching for a better hygiene
  • Doctors Doctors in operation
  • Death and Dying Holding hands
  • Digestive Disorders women suffering from Digestive Disorders
  • Antibiotics and Birth Control Pills Image of antibiotic pills
  • The Morning After Pill Women having a cup of hot drink

Scientific Publications

  • Principles of Gender-Specific Medicine, Third Edition: Gender in the Genomic Era
    Foundation Gala
  • Principles Of Gender-Specific Medicine
    Principles Of Gender-Specific Medicine
  • PRINCIPLES OF GENDER-SPECIFIC MEDICINE TEXTBOOK
    PRINCIPLES OF GENDER-SPECIFIC MEDICINE TEXTBOOK

Our Partners

Partnering with the best in the industry

Stay connected

Submit your email and join our weekly newsletter to stay up-to-date with the Foundation.

Main Menu
  • Home
  • Grants
  • Blog
  • News
  • Events
  • Books
  • Gala
  • Find A Doctor
  • Board Of Directors
  • Contact Us
About Dr. Legato
  • Dr. Legato
  • Curriculum Vitae
  • Scientific Bio
  • Gender Medicine Editorials
  • Selected Articles
About Us
  • About us
  • Our Mission
  • Our Goals
  • Our Team
  • Our Logo
About GSM
  • About GSM
  • Just The Facts
  • Women’s Health
  • Men’s Health
  • Suggested Reading
  • Site Map
  • Privacy Policy

© 2020 All rights reserved www.gendermed.org Developed and powered by www.SlideSigma.com

TOP
MENU
  • DR. LEGATO
    • Scientific Bio
    • Curriculum Vitae
    • Gender Medicine Editorials
    • Selected Articles
  • ABOUT US
    • Just The Facts
    • Our Logo
    • Our Team
    • Our Goals
    • Our Mission
  • ABOUT GSM
    • Suggested Reading
    • Men’s Health
    • Women’s Health
  • PUBLICATIONS
    • Journal
    • Scientific Publications